15 April 2014 - Deborah Wilkes
Archived
Boehringer Ingelheim's Consumer Health Care division reported worldwide sales down by 2.1% to €1.47 billion (US$2.03 billion) in 2013, as sales in Japan fell by 17.9% to €241 million "due to currency effects".
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.